Brightsurf Science News & Current Events

September 20, 2003
Data supports extremely early intervention for multiple sclerosis patients
Immediate initiation of drug treatment with Avonex in individuals considered at risk to develop multiple sclerosis continues to slow the development of MS after five years compared to initiation of therapy more than two years after the onset of symptoms.

Combining osteoporosis drugs produce no added benefit
Combining two types of drugs prescribed for osteoporosis does not produce a synergistic benefit in treating the disease, according to a study headed by a UCSF researcher.

Combining osteoporosis treatments does not produce better results
Combining two currently available types of osteoporosis drugs does not improve bone density, according to a study by researchers at Massachusetts General Hospital. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to